| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $3.0M | — | +65.9% |
| SG&A Expense | $2.1M | — | -23.1% |
| Operating Income | -$5.1M | — | -11.9% |
| Interest Expense | $4K | — | — |
| Income Tax | $0 | — | — |
| Net Income | -$5.0M | — | -0.7% |
| EPS (Basic) | -$1.33 | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.5M | -69.7% | -82.9% |
| Current Assets | $2.9M | -54.2% | -68.9% |
| Total Assets | $5.9M | -38.3% | -48.0% |
| Current Liabilities | $1.8M | +4.0% | -77.7% |
| Total Liabilities | $3.3M | -3.6% | -63.2% |
| Stockholders' Equity |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | — | +17.3% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $952K | — | — |
| Free Cash Flow | -$4.4M | — | +17.9% |
| EPS (Diluted) | -$1.33 | — | -850.0% |
| $2.6M |
| -57.8% |
| +10.6% |